Table 2 Tracer indicators in respective domains of cancer services
From: Assessing service availability and readiness to manage cervical cancer in Bangladesh
Domains | Tracer Items |
|---|---|
Staff and guideline | Oncologists |
Palliative care specialist | |
Trained Nurse | |
Guideline a | |
Training a | |
Equipment | Beds available for cancer patients |
Speculum a | |
Diagnostic facility | Acetic Acid a |
Sputum for Cytology | |
Stool occult blood test (OBT) | |
Cancer antigen 15.3 (CA 15.3) | |
Cancer antigen 19.9 (CA 19.9) | |
Carcinoembryonic antigen (CEA) | |
Cancer antigen 125 (CA125) | |
Alpha Keto Protein | |
Endoscopy of upper gastrointestinal tract | |
Colonoscopy | |
Pituitary tumor-transforming gene 1-binding factor (PBF) | |
Bone Marrow Study | |
Biopsy for Histopathology | |
Fine Needle Aspiration Cytology (FNAC) | |
Medicines | Hydrocortisone |
Pheniramine | |
Ondanseron | |
Haloperidol | |
Morphin injection | |
Morphin tablet | |
Lorazepam | |
Hyoscine butylebromide | |
Broad Spectrum Antibiotics | |
Chemotherapeutic drugs |